Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04788004 · ClinicalTrials.gov registry record
Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse
A clinical trial of Alcohol Use Disorder, sponsored by Virginia Polytechnic Institute and State University.
- Active
- Registry status
- 733
- Enrollment target
- 1
- Study location
NCT04788004: Active study of Alcohol Use Disorder, sponsored by Virginia Polytechnic Institute and State University.
NCT04788004 is a study of Alcohol Use Disorder that is active but no longer recruiting, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 733 participants, above the 324-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (126% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04788004, a study of Alcohol Use Disorder, is active but no longer recruiting, sponsored by Virginia Polytechnic Institute and State University.
- ACTIVE NOT RECRUITING
- Registry status
- 733 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of this study are to provide a scientific understanding of recovery and relapse, as well as to identify novel targets for future relapse prevention interventions.
Primary Outcome
Delay Discounting (DD) task will be administered to assesses the value of delayed reinforcers. Participants make hypothetical choices between amounts of delayed and immediate money at various delays (e.g., 1 day to 25 years)
Conditions Studied
Interventions
- OTHER Online survey
Study Locations (1)
Virginia
- Fralin Biomedical Research Institute at VTC - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 733 participants |
| Start Date | 2022-09-08 |
| Est. Completion | 2026-07-20 |
What the registry record for NCT04788004 still lists
NCT04788004 is an observational study that tracks outcomes without assigning an intervention. The registered 733 participants enrollment target is mid-sized for trials with a published cap, above the 324-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (126% higher).
The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Online survey is the first listed.
NCT04788004 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT04788004 about?
NCT04788004 is a clinical study titled "Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse". The goals of this study are to provide a scientific understanding of recovery and relapse, as well as to identify novel targets for future relapse prevention interventions.
What is the current status of trial NCT04788004?
This trial is currently active not recruiting. The enrollment target is 733 participants. The study started on 2022-09-08. Estimated completion is 2026-07-20.
What conditions does trial NCT04788004 study?
This clinical trial studies the following conditions: Alcohol Use Disorder.
What interventions are being tested in trial NCT04788004?
The interventions under investigation include: Online survey (OTHER).
Who is sponsoring clinical trial NCT04788004?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04788004 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04788004's enrollment target sits among peer trials
733 11th of 184 higher than 174 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
RECRUITING · Phase 2
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06216301 · 734 participants · Phase 3
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- NCT07231419 · 734 participants · Phase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
- NCT05947851 · 735 participants · Phase 3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
- NCT05999084 · 735 participants
Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI